Good morning. Happy Thursday.
The Asian/Pacific markets lean to the downside. Japan and India did well, but Hong Kong, Taiwan, Malaysia, Indonesia, Singapore, Thailand and the Philippines were weak. Europe, Africa and the Middle East currently lean to the upside. Greece is up almost 3%; Turkey is up more than 1%; Finland, Norway, Portugal, Austria and Saudi Arabia are also doing well. South Africa and Hungary are down. Futures in the States point towards a down open for the cash market.
—————
Podcast: with Chat With Traders
—————
The dollar is down. Oil and copper are up. Gold and silver are down. Bonds are down.
Stock headlines from barchart.com…
Archer Daniels Midland (ADM -1.08%) was downgraded to ‘Neutral’ from ‘Buy’ at Citigroup.
Vail Resorts (MTN +1.36%) may open lower this morning after it reported a Q4 Ebitda loss of -$50.4 million, wider than consensus of -$46.6 million, and then said it sees full-year Ebitda of $652 million-$682 million, the midpoint weaker than consensus of $670.1 million.
McCormick (MKC -0.85%) may move higher this morning after it reported Q3 adjusted EPS of $1.12, better than expectations of $1.03, and then said it sees full-year adjusted EPS of $4.20-$4.24, above consensus of $4.07.
Thor Industries (THO +2.35%) climbed nearly 3% in after-hours trading after it reported Q4 EPS from continuing operations of $2.26, well above consensus of $1.96.
Jabil (JBL +3.56%) lost almost 1% in after-hours trading after it forecast Q1 core EPS 65 cents-91 cents, the midpoint below consensus of 83 cents.
Progress Software (PRGS +1.15%) gained 2% in after-hours trading after it said it sees full-year adjusted EPS of $182-$1.85, higher than consensus of $1.80.
Chubb Ltd (CB +0.21%) said its insured losses for Hurricane Harvey are estimated at $650 million pretax, or $520 million after tax, and that losses from Hurricane Irma are estimated at $800 million-$950 million pretax, or $640 million-$750 million after tax.
Abbott Laboratories (ABT -1.32%) rose 2% in after-hours trading after its Freestyle Libre Flash Glucose Monitoring System received FDA approval.
DexCom (DXCM -0.66%) lost 13% in after-hours trading after competitor, Abbott Laboratories, won FDA approval for its Freestyle Libre Flash Glucose Monitoring System.
Comtech Telecommunications (CMTL +4.77%) dropped over 12% in after-hours trading after it reported Q4 net sales of $147.8 million, below consensus of $150.8 million, and said it sees full-year revenue of $550 million-$575 million, the midpoint below consensus of $564.8 million.
Evertec (EVTC -3.86%) was upgraded to ‘Buy’ from ‘Hold’ at Stifel with a 12-month target price of $18.
Pandora (P -1.34%) lost 1% in after-hours trading after it priced 7 million shares of its common stock in a secondary public offering.
Pier 1 Imports (PIR +3.21%) dropped nearly 8% in after-hours trading after it said it cut its full-year net sales estimate to 0% to up +2% from a prior view of +2% to +3%, and lowered its full-year adjusted EPS estimate to 38 cents-48 cents from a previous view of 46 cents-52 cents, the midpoint below consensus of 47 cents.
—————
Join our email list – get technical research reports sent directly to you.
—————
Tuesday’s Key Earnings
Micron (NASDAQ:MU) +4.8% AH on strong memory performance.
Nike (NKE) -3.6% AH with waning demand in N.America.
Today’s Economic Calendar
8:30 GDP Q2
8:30 International trade in goods
8:30 Initial Jobless Claims
8:30 Corporate profits
9:45 Fed’s George: Monetary Policy and Economic Outlook
9:45 Bloomberg Consumer Comfort Index
10:30 EIA Natural Gas Inventory
11:00 Kansas City Fed Mfg Survey
1:00 PM Results of $28B, 7-Year Note Auction
3:00 PM Farm Prices
4:30 PM Money Supply
4:30 PM Fed Balance Sheet
Other…
today’s upgrades/downgrades from briefing.com
this week’s Earnings from Morningstar
this week’s Economic Numbers/Reports powered by ECONODAY
One thought on “Before the Open (Sep 28)”
Leave a Reply
You must be logged in to post a comment.
markets are split,divided and contradicting each other
this is because they suffer schizophrenia and big pharmer has invented
a new pill to drug them and calm them down
actually it is the derivatives that need to be treated as the bears try to force the markets higher to get set